The Combination of Three Components Derived from Sheng MaiSan Protects Myocardial Ischemic Diseases and Inhibits Oxidative Stress via Modulating MAPKs and JAK2-STAT3 Signaling Pathways Based on Bioinformatics Approach

GRS is a drug combination of three components including ginsenoside Rb1, ruscogenin and schisandrin. It derived from the well-known TCM formula Sheng MaiSan, a widely used traditional Chinese medicine for the treatment of cardiovascular diseases in clinic. The present study illuminates its underlyin...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Wydane w:Front Pharmacol
Główni autorzy: Li, Fang, Zhang, Yu, Zeng, Donglin, Xia, Yu, Fan, Xiaoxue, Tan, Yisha, Kou, Junping, Yu, Boyang
Format: Artigo
Język:Inglês
Wydane: Frontiers Media S.A. 2017
Hasła przedmiotowe:
Pharmacology
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5282471/
https://ncbi.nlm.nih.gov/pubmed/28197101
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2017.00021
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy